1. A bivalent antihypertensive vaccine targeting L‐type calcium channels and angiotensin AT1 receptors. (12th December 2019) Authors: Wu, Hailang; Wang, Yiyi; Wang, Gongxin; Qiu, Zhihua; Hu, Xiajun; Zhang, Hongrong; Yan, Xiaole; Ke, Fan; Zou, Anruo; Wang, Min; Liao, Yuhua; Chen, Xiao Journal: British journal of pharmacology Issue: Volume 177:Number 2(2020) Page Start: 402 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Sustained inhibition of the NaV1.7 sodium channel by engineered dimers of the domain II binding peptide GpTx-1. Issue 21 (1st November 2015) Authors: Murray, Justin K.; Biswas, Kaustav; Holder, J. Ryan; Zou, Anruo; Ligutti, Joseph; Liu, Dong; Poppe, Leszek; Andrews, Kristin L.; Lin, Fen-Fen; Meng, Shi-Yuan; Moyer, Bryan D.; McDonough, Stefan I.; Miranda, Les P. Journal: Bioorganic & medicinal chemistry letters Issue: Volume 25:Issue 21(2015) Page Start: 4866 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Sustained inhibition of the NaV1.7 sodium channel by engineered dimers of the domain II binding peptide GpTx-1. Issue 21 (1st November 2015) Authors: Murray, Justin K.; Biswas, Kaustav; Holder, J. Ryan; Zou, Anruo; Ligutti, Joseph; Liu, Dong; Poppe, Leszek; Andrews, Kristin L.; Lin, Fen-Fen; Meng, Shi-Yuan; Moyer, Bryan D.; McDonough, Stefan I.; Miranda, Les P. Journal: Bioorganic & medicinal chemistry letters Issue: Volume 25:Issue 21(2015) Page Start: 4866 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗